SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-249192
Filing Date
2023-10-02
Accepted
2023-10-02 17:15:03
Documents
16
Period of Report
2023-09-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d485845d8k.htm   iXBRL 8-K 35906
2 EX-1.1 d485845dex11.htm EX-1.1 158253
3 EX-4.1 d485845dex41.htm EX-4.1 70608
4 EX-5.1 d485845dex51.htm EX-5.1 12429
8 GRAPHIC g485845g0930025419671.jpg GRAPHIC 2213
  Complete submission text file 0001193125-23-249192.txt   481031

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA mdgl-20230928.xsd EX-101.SCH 2871
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE mdgl-20230928_lab.xml EX-101.LAB 18757
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mdgl-20230928_pre.xml EX-101.PRE 11724
10 EXTRACTED XBRL INSTANCE DOCUMENT d485845d8k_htm.xml XML 3503
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33277 | Film No.: 231300655
SIC: 2834 Pharmaceutical Preparations